Nonsteroidal antiinflammatory drug-exacerbated respiratory disease: molecular mechanism, management and treatment
J. J. Ley-Tomas, A. M. Xicotencatl-Tellez, M. L. García-Cruz, M. A. Jiménez-Chobillon · 2024
Read Nonsteroidal antiinflammatory drug-exacerbated respiratory disease: molecular mechanism, management and treatment by J. J. Ley-Tomas, A. M. Xicotencatl-Tellez, M. L. García-Cruz, M. A. Jiménez-Chobillon (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11631927.txt.
Description
Ley-Tomas and three co-authors review NSAID-exacerbated respiratory disease, its mechanisms, care and treatment, in work from 2024. The syndrome combines asthma, chronic rhinosinusitis with nasal polyps, and intolerance to aspirin and similar drugs. It may affect many people in the United States, and many cases need a provocation test to confirm.
The disease rests on an imbalance in the arachidonic acid pathway, and it tends to be severe even with full standard care. Polyps in the sinuses are often aggressive and return. New monoclonal antibodies that cut type 2 inflammation show strong promise for control, the authors report. The review gathers recent proof on causes, diagnosis and therapy choices.
Catalog record
| CREATOR | J. J. Ley-Tomas, A. M. Xicotencatl-Tellez, M. L. García-Cruz, M. A. Jiménez-Chobillon |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |